trending Market Intelligence /marketintelligence/en/news-insights/trending/erhv3jkbaje78q-o22gxaw2 content esgSubNav
In This List

Entellus Medical shareholders approve Stryker merger

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Entellus Medical shareholders approve Stryker merger

Entellus Medical Inc. shareholders approved the Minnesota-based medical technology company's previously announced merger with Stryker Corp.

Shareholders voted to approve the deal at a special meeting held Feb. 26.

Under the transaction, which was recently cleared by the U.S. Federal Trade Commission, Michigan-based Stryker will pay Entellus shareholders $24 per share.

Entellus Medical makes products for the minimally invasive treatment of patients with chronic and recurrent sinusitis.